Prosecution Insights
Last updated: October 01, 2026
Application No. 18/637,148

SYSTEM AND METHOD FOR DEFORMING AND ANALYZING PARTICLES

Non-Final OA §102§DP
Filed
Apr 16, 2024
Priority
Oct 24, 2012 — provisional 61/718,077 +7 more
Examiner
SIEFKE, SAMUEL P
Art Unit
Tech Center
Assignee
The Regents of the University of California
OA Round
1 (Non-Final)
63%
Grant Probability
Moderate
1-2
OA Rounds
11m
Est. Remaining
81%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
664 granted / 1053 resolved
+3.1% vs TC avg
Strong +18% interview lift
Without
With
+17.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
33 currently pending
Career history
1079
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
30.8%
-9.2% vs TC avg
§102
38.5%
-1.5% vs TC avg
§112
10.1%
-29.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1053 resolved cases

Office Action

§102 §DP
Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claims 1-9 are rejected under pre-AIA 35 U.S.C. 102b as being anticipated by Gossett, D.R. et al. “Deformabitly Cytometry: High-throughput, Continuous Measurement of Cell Mechanical Properties in Extension flow”, 14th International Conference on Miniaturized Systems for Chemistry and Life Science 3-7 October 2010, Groningen, The Netherlands, 1382-1384. Regarding claim 1, Gossett discloses a system (Fig. 1a-1e) for deforming a plurality of particles carried in a sample volume, the system comprising: a reusable substrate (see 1a, 1e. regarding the reusable limitation, this limitation does not further structurally limit the substrate because there is not structure that is related to being reusable. Reusable is drawn to a process/intended use and there is no structure that differentiates from the prior art with respect to being reusable) defining an inlet (fig. 1b, left side inlet or right side inlet), configured to receive the sample volume (this limitation does not further structurally limit the instant claims as the sample volume is not positively claimed and can be added to the inlet at a later time), and an outlet (fig. 1a 1b, top or bottom outlet from deformation and measurement region), wherein the inlet or outlet is configured to couple to a module to introduce or collect a washing or a flushing solution (this limitation does not further structurally limit the instant claim as there is not structure associated with the coupling of the substrate to a module. The outlet is capable of being connected to a collection device and the inlets are capable of being connected to a feeding conduit as shown in fig. 1a, 1e); a fluidic pathway (any number of channels that are shown in fig. 1a-1e, that is capable of passing a fluid) disposed in the reusable substrate and fluidically coupled to the inlet and the outlet and comprising: a delivery region (inertial focusers as seen in fig. 1a) fluidically coupled to the inlet and configured to focus the plurality of particles along at least one streamline (there is no structure related to what focus the plurality of particles. The broadest reasonable interpretation is a straight channel with a length. Fig. 1a shows a series of rising peaks within the delivery region); and a deformation region (fig. 1b) located downstream with respect to the delivery region (inertial focusers) and formed by an intersection of the fluidic pathway and an opposing inlet channel (four channels converge, two inlets and two outlets), wherein flow of a fluid from the opposing inlet channel at the intersection mechanically deforms the plurality of particles passing through the deformation region (this limitation does not further structurally limit the instant claim as the flow of a fluid is not positively recited and application has not positively claimed for example a second inlet to the deformation that is opposite the first inlet). Regarding claim 2, the system of claim 1, wherein the reusable substrate is configured for washing and reuse (this limitation does not further structurally limit the instant claims as it is directed to a process/intended use limitation). Regarding claim 3, the system of claim 2, wherein the reusable substrate is self-washing (this limitation does not further structurally limit the instant claims as it is directed to a process/intended use limitation). Regarding claim 4, the system of claim 1, wherein the reusable substrate is reusable for a plurality of uses and is configured to be replaceable (this limitation does not further structurally limit the instant claims as it is directed to a process/intended use limitation. Further there is no structure that differentiates from the prior art with respect to being reusable). Regarding claim 5, the system of claim 4, wherein the reusable substrate comprises aligners (see fig. 1e which has corners that are broadly interpreted as aligners as it provides a reference to the detector for alignment purposes) that align the reusable substrate relative to a detection module configured to capture a morphology dataset comprising multiple positions and/or deformations of the plurality of particles upstream and downstream of the deformation region (A detection module is not positively recited in the instant claims as it can be connected to the substrate at a later time. Further the process/intended use limitation doe not further structurally limit the instant claims with respect to detecting particles as the detection module is not positively recited). Regarding claim 6, the system of claim 4, wherein the system is configured to be reusable for a certain number of uses (this limitation does not further structurally limit the instant claims as it is directed to a process/intended use limitation. Further there is no structure that differentiates from the prior art with respect to being reusable). Regarding claim 7, the system of claim 4, wherein the system is configured it be reusable until failure by clogging (this limitation does not further structurally limit the instant claims as it is directed to a process/intended use limitation. Further there is no structure that differentiates from the prior art with respect to being reusable until failure by clogging). Regarding claim 8, Gossett discloses a method of using the system of claim 1, comprising: introducing a first sample volume into the inlet and mechanically deforming the plurality of particles therein (a first sample is introduced into the device as shown in fig. 1a); introducing the washing or the flushing solution into the inlet or outlet from the module (a module as recited in claim 1 is not positively recited as part of the system. The system as recited in claim 1 comprises a substrate and a fluidic pathway with a delivery region and a deformation region. The system of claim 1 only requires that the system be capable of connecting to a module. Gossett is provided with various inlets and outlets that are capable of connecting to modules for input or collecting various fluids from the system); introducing one or more additional sample volumes into the inlet and mechanically deforming the plurality of particles therein (see fig. 1a-1e), wherein the washing or the flushing solution is introduced into the inlet or outlet from the module prior to the one or more additional sample volumes being introduced into the inlet (A first sample is inputted into the system and a detection of deformation is recorded. A second sample test introduced after the first sample is run broadly reads on this limitation as the washing or flushing solution is not defined as being different that a sample fluid). Regarding claim 9, the method of claim 8 comprising replacing the reusable substrate with another reusable substrate and introducing another sample volume into the inlet and mechanically deforming the plurality of particles therein (A first sample is inputted into the system and a detection of deformation is recorded. A second sample test introduced after the first sample is run broadly reads on this limitation as the washing or flushing solution is not defined as being different that a sample fluid). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 1-9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-13 of U.S. Patent No. 10,969,327. Although the claims at issue are not identical, they are not patentably distinct from each other because the instant claims are broader than US 10,969,327 and therefore are fully encompassed by the claims. Claims 1-9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-15 of U.S. Patent No. 10,295,455. Although the claims at issue are not identical, they are not patentably distinct from each other because the instant claims are broader than US 10,295,455 and therefore are fully encompassed by the claims. Claims 1-9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-5 of U.S. Patent No. 10,107,735. Although the claims at issue are not identical, they are not patentably distinct from each other because the instant claims are broader than US 10,107,735 and therefore are fully encompassed by the claims. Claims 1-9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-10 of U.S. Patent No. 9,464,977. Although the claims at issue are not identical, they are not patentably distinct from each other because the instant claims are broader than US 9,464,977 and therefore are fully encompassed by the claims. Claims 1-9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-16 of U.S. Patent No. 9,151,705. Although the claims at issue are not identical, they are not patentably distinct from each other because the instant claims are broader than US 9,151,705 and therefore are fully encompassed by the claims. Claims 1-9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-16 of U.S. Patent No. 9,638,620. Although the claims at issue are not identical, they are not patentably distinct from each other because the instant claims are broader than US 9,638,620 and therefore are fully encompassed by the claims. Claims 1-9 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-12 of U.S. Patent No. 12,007,321. Although the claims at issue are not identical, they are not patentably distinct from each other because the instant claims are broader than US 12,007,321 and therefore are fully encompassed by the claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SAMUEL P SIEFKE whose telephone number is (571)272-1262. The examiner can normally be reached Monday-Friday 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Maris Kessel can be reached at 571-270-7698. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SAMUEL P SIEFKE/Primary Examiner, Art Unit 1758
Read full office action

Prosecution Timeline

Apr 16, 2024
Application Filed
Sep 03, 2026
Non-Final Rejection mailed — §102, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742736
CHROMATOGRAPHIC STRIP SUPPORT TOOL AND METHOD FOR USING SAME
3y 6m to grant Granted Sep 22, 2026
Patent 12733850
Small Volume Collection Container
4y 6m to grant Granted Sep 15, 2026
Patent 12728422
DELIVERY CONSUMABLE FOR DELIVERING A FLUID TO A BIOREACTOR
4y 0m to grant Granted Sep 08, 2026
Patent 12730057
SYSTEM AND METHOD FOR DEFORMING AND ANALYZING PARTICLES
1y 7m to grant Granted Sep 08, 2026
Patent 12722151
ANALYTE METERS, TEST STRIP EJECTORS, AND METHODS OF USING SAME
4y 7m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
63%
Grant Probability
81%
With Interview (+17.8%)
3y 4m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1053 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month